Terms: = Bone cancer AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Prognosis
14 results:
1. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo.
Spohr C; Poggio T; Andrieux G; Schönberger K; Cabezas-Wallscheid N; Boerries M; Halbach S; Illert AL; Brummer T
Leukemia; 2022 Apr; 36(4):970-982. PubMed ID: 34903841
[TBL] [Abstract] [Full Text] [Related]
2. Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
Matrone A; Prete A; Nervo A; Ragni A; Agate L; Molinaro E; Giani C; Valerio L; Minaldi E; Piovesan A; Elisei R
J Endocrinol Invest; 2021 Oct; 44(10):2139-2151. PubMed ID: 33594641
[TBL] [Abstract] [Full Text] [Related]
3. Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid cancer.
Koehler VF; Adam P; Frank-Raue K; Raue F; Berg E; Hoster E; Allelein S; Schott M; Kroiss M; Spitzweg C
Thyroid; 2021 Mar; 31(3):459-469. PubMed ID: 32781914
[No Abstract] [Full Text] [Related]
4. Tumor-Specific Regulatory T Cells from the bone Marrow Orchestrate Antitumor Immunity in Breast cancer.
Ge Y; Böhm HH; Rathinasamy A; Xydia M; Hu X; Pincha M; Umansky L; Breyer C; Hillier M; Bonertz A; Sevko A; Domschke C; Schuetz F; Frebel H; Dettling S; Herold-Mende C; Reissfelder C; Weitz J; Umansky V; Beckhove P
Cancer Immunol Res; 2019 Dec; 7(12):1998-2012. PubMed ID: 31672785
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA MALAT1 Promotes cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
Chen Y; Huang W; Sun W; Zheng B; Wang C; Luo Z; Wang J; Yan W
Cell Physiol Biochem; 2018; 51(3):1313-1326. PubMed ID: 30481748
[TBL] [Abstract] [Full Text] [Related]
6. Hyaluronic acid-CD44 interactions promote BMP4/7-dependent Id1/3 expression in melanoma cells.
Wu RL; Sedlmeier G; Kyjacova L; Schmaus A; Philipp J; Thiele W; Garvalov BK; Sleeman JP
Sci Rep; 2018 Oct; 8(1):14913. PubMed ID: 30297743
[TBL] [Abstract] [Full Text] [Related]
7. Cabozantinib: Multi-kinase Inhibitor of MET, AXL, ret, and VEGFR2.
Grüllich C
Recent Results Cancer Res; 2018; 211():67-75. PubMed ID: 30069760
[TBL] [Abstract] [Full Text] [Related]
8. An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter.
Huo Y; Su T; Cai Q; Macara IG
Cell Rep; 2016 Jun; 15(10):2089-2096. PubMed ID: 27239038
[TBL] [Abstract] [Full Text] [Related]
9. Outcomes of unplanned sarcoma excision: impact of residual disease.
Charoenlap C; Imanishi J; Tanaka T; Slavin J; Ngan SY; Chander S; Dowsey MM; Goyal C; Choong PF
Cancer Med; 2016 Jun; 5(6):980-8. PubMed ID: 26929181
[TBL] [Abstract] [Full Text] [Related]
10. Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure.
Ho WL; Zacharin MR
Eur J Pediatr; 2016 May; 175(5):677-83. PubMed ID: 26805408
[TBL] [Abstract] [Full Text] [Related]
11. [Comprehensive analysis of genomic detection for a patient with myelodysplastic syndrome].
Luo JX; Ai C; Huang YS; Wang HW; Hu CM; Zhao WW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1501-6. PubMed ID: 24370037
[TBL] [Abstract] [Full Text] [Related]
12. Medullary thyroid cancer: early detection and novel treatments.
Roman S; Mehta P; Sosa JA
Curr Opin Oncol; 2009 Jan; 21(1):5-10. PubMed ID: 19125012
[TBL] [Abstract] [Full Text] [Related]
13. MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
Castellani MR; Seregni E; Maccauro M; Chiesa C; Aliberti G; Orunesu E; Bombardieri E
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):430-40. PubMed ID: 19088696
[TBL] [Abstract] [Full Text] [Related]
14. Frequent loss of heterozygosity for markers on chromosome arm 10q in chondrosarcomas.
Raskind WH; Conrad EU; Matsushita M
Genes Chromosomes Cancer; 1996 Jun; 16(2):138-43. PubMed ID: 8818661
[TBL] [Abstract] [Full Text] [Related]
